Partners Value Investments L.P.Partners Value Investments L.P.

Institutional investor · Portfolio as of Q2 2026

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

BROOKFIELD CORP

181.4M$7.7B78.9%$29.12+41.91%
12 qtrssince 2023-Q3
Unchanged
0

BROOKFIELD ASSET MANAGMT LTD

29.6M$1.3B13.5%$30.97+68.29%
12 qtrssince 2023-Q3
Unchanged
0

Brookfield Wealth Solut

12.3M$525.6M5.4%$39.08+5.85%
8 qtrssince 2024-Q3
Unchanged
0
5.2M$153.9M1.6%$34.91-19.88%
2 qtrssince 2026-Q1
Decreased
0
DEODEO
ADR

DIAGEO PLC

609,150$49M0.5%$80.38+15.69%
1 qtr
New
51

ALPHABET INC

22,500$7.9M0.1%$177.99+92.64%
5 qtrssince 2025-Q2
Unchanged
0

META PLATFORMS INC

11,619$6.5M0.1%$732.54-21.09%
5 qtrssince 2025-Q2
Unchanged
0
$9.8B
AUM
7
Positions
Q2 2026
Filing
3.0/5
HI score
Quarterly 13F Value Change
-9%Q1'25$8.4B+18%Q2'25$9.9B+9%Q3'25$10.8B-1%Q4'25$10.7B-13%Q1'26$9.3B+5%Q2'26$9.8B
Activity profile
$ moved · Q2'26
New82%Increased0%Decreased18%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q14%1-4Q14%1-2Y43%2Y+29%

Partners Value Investments L.P. manages $9.8B across 7 positions as of Q2 2026. Top holdings: BN (78.9%), BAM (13.5%), BNT (5.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Added 1 new position, trimmed 1. Top move: DEO (NEW, conviction 51). Portfolio: $9.8B across 7 positions.

Top holdings by portfolio weight

Total AUM$10B
BN78.87%
BAM13.55%
BNT5.37%
BBUC1.57%
DEO0.50%
GOOG0.08%
META0.07%

Portfolio allocation by GICS sector

Sectors3
Financial Services99.34%
Consumer Defensive0.51%
Communication Services0.15%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L72
Conviction40
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used